Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy ; volume:146 ; number:3 ; day:24 ; month:6 ; year:2023 ; pages:395-414 ; date:9.2023
Acta neuropathologica ; 146, Heft 3 (24.6.2023), 395-414, 9.2023
- Urheber
-
Forrest, Shelley L.
Lee, Seojin
Nassir, Nasna
Martinez-Valbuena, Ivan
Sackmann, Valerie
Li, Jun
Ahmed, Awab
Tartaglia, Maria Carmela
Ittner, Lars M.
Lang, Anthony E.
Uddin, Mohammed
Kovacs, Gabor Geza
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-023-02604-x
- URN
-
urn:nbn:de:101:1-2023110209101486200128
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Forrest, Shelley L.
- Lee, Seojin
- Nassir, Nasna
- Martinez-Valbuena, Ivan
- Sackmann, Valerie
- Li, Jun
- Ahmed, Awab
- Tartaglia, Maria Carmela
- Ittner, Lars M.
- Lang, Anthony E.
- Uddin, Mohammed
- Kovacs, Gabor Geza
- SpringerLink (Online service)
Ähnliche Objekte (12)
Progressive Supranuclear Palsy
The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy
Multireceptor fingerprints in progressive supranuclear palsy
Autonomic dysfunction in progressive supranuclear palsy
Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
Modifizierung der Progressive Supranuclear Palsy Rating Scale
Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes
Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy
Imaging in the diagnosis of progressive supranuclear palsy
SUMO1 Modification of Tau in Progressive Supranuclear Palsy
Author Correction: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes
Distribution patterns of tau pathology in progressive supranuclear palsy
Progressive Supranuclear Palsy
The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy
Multireceptor fingerprints in progressive supranuclear palsy
Autonomic dysfunction in progressive supranuclear palsy
Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
Modifizierung der Progressive Supranuclear Palsy Rating Scale
Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes
Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy
Imaging in the diagnosis of progressive supranuclear palsy
SUMO1 Modification of Tau in Progressive Supranuclear Palsy
Author Correction: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes
Distribution patterns of tau pathology in progressive supranuclear palsy
Progressive Supranuclear Palsy
The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy
Multireceptor fingerprints in progressive supranuclear palsy
Autonomic dysfunction in progressive supranuclear palsy
Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
Modifizierung der Progressive Supranuclear Palsy Rating Scale
Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes
Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy
Imaging in the diagnosis of progressive supranuclear palsy
SUMO1 Modification of Tau in Progressive Supranuclear Palsy
Author Correction: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes